Effectiveness and cost-effectiveness of Levonorgestrel containing Intrauterine system in primary care against standard treatment for menorrhagia.

Trial Profile

Effectiveness and cost-effectiveness of Levonorgestrel containing Intrauterine system in primary care against standard treatment for menorrhagia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2015

At a glance

  • Drugs Levonorgestrel (Primary) ; Combined oral contraceptives; Medroxyprogesterone; Mefenamic acid; Norethisterone; Progesterone congeners; Tranexamic acid
  • Indications Menorrhagia
  • Focus Therapeutic Use
  • Acronyms ECLIPSE
  • Most Recent Events

    • 13 Feb 2015 According to the the ISRCTN: Current Controlled Trials record, status changed from active, no longer recruiting to completed.
    • 10 Jan 2013 Primary endpoint 'Assessment-scale-scores' has been met.
    • 10 Jan 2013 Results published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top